New patent for Exelixis drug COMETRIQ

   April 14, 2022    Comments Off on New patent for Exelixis drug COMETRIQ    Posted in: Patent Added

Annual Drug Patent Expirations for COMETRIQ Cometriq is a drug marketed by Exelixis and is included in one NDA. It is available from one supplier. There are six patents protecting…

The post New patent for Exelixis drug COMETRIQ appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog